Male Infertility Market To Surpass USD 5,885 Million By 2030 At A CAGR Of 5.0%
The report analyzes and forecasts the Male Infertility Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Male Infertility Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Male Infertility Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Male Infertility Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2960
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
Some of the top vendors offered in the professional report include Andrology solutions, Halotech DNA SL, AytuBioScience, Inc., Bayer Healthcare, EMD Sereno, Inc., Cadila Healthcare Ltd., SCSA Diagnostics, Inc., and Intas Pharmaceuticals Ltd.
The major market segments of Male Infertility Market are as below:
Market by Test
· Oxidative Stress Analysis
· DNA Fragmentation Technique
· Microscopic Examination
· Sperm Agglutination
· Computer Assisted Semen Analysis
· Sperm Penetration Assay
· Others
Market by Treatment
- Medication
- Assisted Reproductive Technology and Varicocele Surgery
Market by End-User
- Hospitals and Clinics
- Fertility Centers
- Research Institutes
- Others
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of Male Infertility Market
1.1. Definition and Scope
1.1.1. Definition of Male Infertility
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Male Infertility Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Male Infertility Market By Test
1.2.3. Male Infertility Market By Treatment
1.2.4. Male Infertility Market By End-User
1.2.5. Male Infertility Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Male Infertility Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Male Infertility Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Male Infertility Market By Test
4.1. Introduction
4.2. Male InfertilityRevenueBy Test
4.2.1. Male Infertility Revenue (US$ Mn) and Forecast, By Test, 2018-2030
4.2.2. Oxidative Stress Analysis
4.2.2.1. Oxidative Stress Analysis Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.3. DNA Fragmentation Technique
4.2.3.1. DNA Fragmentation Technique Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.4. Microscopic Examination
4.2.4.1. Microscopic Examination Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.5. Sperm Agglutination
4.2.5.1. Sperm Agglutination Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.6. Computer Assisted Semen Analysis
4.2.6.1. Computer Assisted Semen Analysis Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.7. Sperm Penetration Assay
4.2.7.1. Sperm Penetration Assay Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.8. Others
4.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 5. Male Infertility Market By Treatment
5.1. Introduction
5.2. Male Infertility Revenue (US$ Mn) By Treatment
5.2.1. Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
5.2.2. Assisted Reproductive Technology and Varicocele Surgery
5.2.2.1. Assisted Reproductive Technology and Varicocele SurgeryMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.3. Medication
5.2.3.1. Medication Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 6. Male Infertility Market By End-User
6.1. Introduction
6.2. Male Infertility Revenue (US$ Mn) By End-User
6.2.1. Male Infertility Revenue (US$ Mn) and Forecast By End-User, 2018-2030
6.2.2. Hospitals & Clinics
6.2.2.1. Hospitals & Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.3. Fertility Centers
6.2.3.1. Fertility Centers Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.4. Research Institutes
6.2.4.1. Research Institutes Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.5. Others
6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 7. North AmericaMale Infertility Market By Country
7.1. North America Male InfertilityOverview
7.2. U.S.
7.2.1. U.S. Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
7.2.2. U.S. Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
7.2.3. U.S. Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
7.3. Canada
7.3.1. Canada Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
7.3.2. Canada Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
7.3.3. Canada Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Male Infertility Market By Country
8.1. Europe Male InfertilityOverview
8.2. U.K.
8.2.1. U.K.Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
8.2.2. U.K. Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
8.2.3. U.K. Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
8.3. Germany
8.3.1. Germany Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
8.3.2. Germany Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
8.3.3. Germany Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
8.4. France
8.4.1. France Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
8.4.2. France Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
8.4.3. France Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
8.5. Spain
8.5.1. Spain Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
8.5.2. Spain Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
8.5.3. Spain Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
8.6.2. Rest of Europe Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
8.6.3. Rest of Europe Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Male Infertility Market By Country
9.1. Asia Pacific Male InfertilityOverview
9.2. China
9.2.1. China Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.2.2. China Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.2.3. China Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.3. Japan
9.3.1. Japan Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.3.2. Japan Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.3.3. Japan Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.4. India
9.4.1. India Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.4.2. India Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.4.3. India Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.5. Australia
9.5.1. Australia Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.5.2. Australia Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.5.3. Australia Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.6. South Korea
9.6.1. South Korea Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.6.2. South Korea Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.6.3. South Korea Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-PacificMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.7.2. Rest of Asia-Pacific Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.7.3. Rest of Asia-Pacific Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Male Infertility Market By Country
10.1. Latin AmericaMale InfertilityOverview
10.2. Brazil
10.2.1. Brazil Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
10.2.2. Brazil Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
10.2.3. Brazil Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
10.3. Mexico
10.3.1. MexicoMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
10.3.2. Mexico Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
10.3.3. Mexico Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin AmericaMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
10.4.2. Rest of Latin America Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
10.4.3. Rest of Latin America Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Male Infertility Market By Country
11.1. Middle East & Africa Male InfertilityOverview
11.2. GCC
11.2.1. GCCMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
11.2.2. GCC Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
11.2.3. GCC Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
11.3. South Africa
11.3.1. South AfricaMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
11.3.2. GCC Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
11.3.3. GCCMale Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & AfricaMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
11.4.2. Rest of Middle East & Africa Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
11.4.3. Rest of Middle East & Africa Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Male Infertility Market
12.1. Male Infertility MarketCompany Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition InGlobal Male Infertility Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Andrology Solutions
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2021
13.1.3.2. Andrology solutions2021 Male InfertilityBusiness Regional Distribution
13.1.4. Product/Service Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. ManufacturingPlant Footprint Analysis
13.2. AytuBioScience, Inc.
13.3. Bayer Healthcare
13.4. Cadila Healthcare Ltd.
13.5. EMD Sereno, Inc.
13.6. Halotech DNA SL
13.7. Intas Pharmaceuticals Ltd.
13.8. SCSA Diagnostics, Inc.
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2960
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
